Stonepine Capital Management »

Arvinas Ord shares owned by Stonepine Capital Management

Quarter-by-quarter ownership of Arvinas Ord (ARVN) shares owned by Stonepine Capital Management from 13F filings

Historical chart of Stonepine Capital Management investment in Arvinas Ord

Tip: Access up to 7 years of quarterly data

All positions including Arvinas Ord held by Stonepine Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arvinas Ord by Stonepine Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $292k 28k 10.60

More positions owned by Stonepine Capital Management

Spdr Series Trust State Street Spd Put Option (XBI)
Verastem Com New (VSTM)
Adma Biologics (ADMA)
Tenax Therapeutics Com New (TENX)
Evolus (EOLS)
Camp4 Therapeutics Corp (CAMP)
Nektar Therapeutics Com New (NKTR)
Terns Pharmaceuticals Call Option (TERN)
Zevra Therapeutics Com New (ZVRA)
Abeona Therapeutics Com New (ABEO)
Corbus Pharmaceuticals Hldgs Com New (CRBP)
Establishment Labs Holdings Ord Call Option (ESTA)
Kazia Therapeutics Sponsored Ads (KZIA)
An2 Therapeutics (ANTX)
Alexandria Real Estate Equities Call Option (ARE)

View all positions for Stonepine Capital Management

Top funds holding Arvinas Ord

BlackRock
Vanguard Portfolio Management
D. E. Shaw & Co
Pfizer
Vanguard Capital Management
TCG Crossover Management
Armistice Capital
Two Sigma Investments
State Street Corporation
Geode Capital Management
Jacobs Levy Equity Management
Citadel Advisors
Qube Research & Technologies
Federated Investors
Acadian Asset Management

View all funds holding Arvinas Ord